Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production

Kazuhiro Takahashi; Fumitoshi Satoh; Eishi Hara; Masahiko Sone; Osamu Murakami; Takamasa Kayama; Takashi Yoshimoto; Shigeki Shibahara

doi:10.1016/S0196-9781(97)00186-1

Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production

Kazuhiro Takahashi, Fumitoshi Satoh, Eishi Hara, Masahiko Sone, Osamu Murakami, Takamasa Kayama, Takashi Yoshimoto, Shigeki Shibahara

Research output: Contribution to journal › Article › peer-review

65 Citations (Scopus)

Abstract

The expression of adrenomedullin (ADM) and its mRNA was studied in human glial cell tumors and cultured glioblastoma cell lines. T98G and A172 Northern blot analysis showed that ADM mRNA was expressed in all brain tumors examined (three anaplastic astrocytomas and two glioblastomas multiforme) and in the glioblastoma cell lines. Immunoreactive (IR-)ADM was detectable in these brain tumors by radioimmunoassays (0.31-2.0 pmol/g wet weight), except for one anaplastic astrocytoma. Reverse phase high performance liquid chromatography of the tumor extracts showed a single peak eluting in the position of ADM-(1-52), IR-ADM concentrations in the cultured media of T98G cells were 205.5 ± 8.4 fmol/10⁵ cells/24 h (mean ± SEM, n = 5). Treatment of T98G cells with interferon γ or interleukin 1β increased the expression levels of ADM mRNA and the IR-ADM concentrations in the cultured media, whereas tumor necrosis factor α decreased them in a dose dependent manner. Treatment with synthetic ADM-(1-52) (10^-8 or 10^-7 mol/l) increased the cAMP concentrations in the cultured media of T98G cells. These findings suggest that ADM is secreted from glial cell tumors and is related to the pathophysiology of these tumors.

Original language	English
Pages (from-to)	1117-1124
Number of pages	8
Journal	Peptides
Volume	18
Issue number	8
DOIs	https://doi.org/10.1016/S0196-9781(97)00186-1
Publication status	Published - 1997

Keywords

Adrenomedullin
Astrocytoma
Brain tumor
Cytokine
Glia
Glioblastoma

ASJC Scopus subject areas

Biochemistry
Physiology
Endocrinology
Cellular and Molecular Neuroscience

Access to Document

10.1016/S0196-9781(97)00186-1

Cite this

@article{607f69019004430291059306a10e1b88,

title = "Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production",

abstract = "The expression of adrenomedullin (ADM) and its mRNA was studied in human glial cell tumors and cultured glioblastoma cell lines. T98G and A172 Northern blot analysis showed that ADM mRNA was expressed in all brain tumors examined (three anaplastic astrocytomas and two glioblastomas multiforme) and in the glioblastoma cell lines. Immunoreactive (IR-)ADM was detectable in these brain tumors by radioimmunoassays (0.31-2.0 pmol/g wet weight), except for one anaplastic astrocytoma. Reverse phase high performance liquid chromatography of the tumor extracts showed a single peak eluting in the position of ADM-(1-52), IR-ADM concentrations in the cultured media of T98G cells were 205.5 ± 8.4 fmol/105 cells/24 h (mean ± SEM, n = 5). Treatment of T98G cells with interferon γ or interleukin 1β increased the expression levels of ADM mRNA and the IR-ADM concentrations in the cultured media, whereas tumor necrosis factor α decreased them in a dose dependent manner. Treatment with synthetic ADM-(1-52) (10-8 or 10-7 mol/l) increased the cAMP concentrations in the cultured media of T98G cells. These findings suggest that ADM is secreted from glial cell tumors and is related to the pathophysiology of these tumors.",

keywords = "Adrenomedullin, Astrocytoma, Brain tumor, Cytokine, Glia, Glioblastoma",

author = "Kazuhiro Takahashi and Fumitoshi Satoh and Eishi Hara and Masahiko Sone and Osamu Murakami and Takamasa Kayama and Takashi Yoshimoto and Shigeki Shibahara",

note = "Funding Information: This work was supported in part by Grants-in-aid for Scientific Research (B) and (C) from the Ministry of Education, Science, Sports and Culture of Japan.",

year = "1997",

doi = "10.1016/S0196-9781(97)00186-1",

language = "English",

volume = "18",

pages = "1117--1124",

journal = "Peptides",

issn = "0196-9781",

publisher = "Elsevier Inc.",

number = "8",

}

TY - JOUR

T1 - Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production

AU - Takahashi, Kazuhiro

AU - Satoh, Fumitoshi

AU - Hara, Eishi

AU - Sone, Masahiko

AU - Murakami, Osamu

AU - Kayama, Takamasa

AU - Yoshimoto, Takashi

AU - Shibahara, Shigeki

N1 - Funding Information: This work was supported in part by Grants-in-aid for Scientific Research (B) and (C) from the Ministry of Education, Science, Sports and Culture of Japan.

PY - 1997

Y1 - 1997

N2 - The expression of adrenomedullin (ADM) and its mRNA was studied in human glial cell tumors and cultured glioblastoma cell lines. T98G and A172 Northern blot analysis showed that ADM mRNA was expressed in all brain tumors examined (three anaplastic astrocytomas and two glioblastomas multiforme) and in the glioblastoma cell lines. Immunoreactive (IR-)ADM was detectable in these brain tumors by radioimmunoassays (0.31-2.0 pmol/g wet weight), except for one anaplastic astrocytoma. Reverse phase high performance liquid chromatography of the tumor extracts showed a single peak eluting in the position of ADM-(1-52), IR-ADM concentrations in the cultured media of T98G cells were 205.5 ± 8.4 fmol/105 cells/24 h (mean ± SEM, n = 5). Treatment of T98G cells with interferon γ or interleukin 1β increased the expression levels of ADM mRNA and the IR-ADM concentrations in the cultured media, whereas tumor necrosis factor α decreased them in a dose dependent manner. Treatment with synthetic ADM-(1-52) (10-8 or 10-7 mol/l) increased the cAMP concentrations in the cultured media of T98G cells. These findings suggest that ADM is secreted from glial cell tumors and is related to the pathophysiology of these tumors.

AB - The expression of adrenomedullin (ADM) and its mRNA was studied in human glial cell tumors and cultured glioblastoma cell lines. T98G and A172 Northern blot analysis showed that ADM mRNA was expressed in all brain tumors examined (three anaplastic astrocytomas and two glioblastomas multiforme) and in the glioblastoma cell lines. Immunoreactive (IR-)ADM was detectable in these brain tumors by radioimmunoassays (0.31-2.0 pmol/g wet weight), except for one anaplastic astrocytoma. Reverse phase high performance liquid chromatography of the tumor extracts showed a single peak eluting in the position of ADM-(1-52), IR-ADM concentrations in the cultured media of T98G cells were 205.5 ± 8.4 fmol/105 cells/24 h (mean ± SEM, n = 5). Treatment of T98G cells with interferon γ or interleukin 1β increased the expression levels of ADM mRNA and the IR-ADM concentrations in the cultured media, whereas tumor necrosis factor α decreased them in a dose dependent manner. Treatment with synthetic ADM-(1-52) (10-8 or 10-7 mol/l) increased the cAMP concentrations in the cultured media of T98G cells. These findings suggest that ADM is secreted from glial cell tumors and is related to the pathophysiology of these tumors.

KW - Adrenomedullin

KW - Astrocytoma

KW - Brain tumor

KW - Cytokine

KW - Glia

KW - Glioblastoma

UR - http://www.scopus.com/inward/record.url?scp=0031443529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031443529&partnerID=8YFLogxK

U2 - 10.1016/S0196-9781(97)00186-1

DO - 10.1016/S0196-9781(97)00186-1

M3 - Article

C2 - 9396051

AN - SCOPUS:0031443529

VL - 18

SP - 1117

EP - 1124

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 8

ER -

Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this